The CheckMate 9LA Trial for Stage IV/Recurrent Non-Small Cell Lung Cancer

0 Views
administrator
administrator
07/07/23

Martin Reck, MD, PhD, presents data from the CheckMate 9LA trial of nivolumab, ipilimumab, and 2 cycles of platinum-doublet chemotherapy for stage IV/recurrent non-small cell lung cancer.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next